Related Experiment Videos

The genetic basis of autosomal dominant familial Mediterranean fever

D R Booth1, J D Gillmore, H J Lachmann

  • 1Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Royal Free Campus, London, UK.

Insights

Familial Mediterranean fever (FMF) can be inherited dominantly, not just recessively. Genetic analysis confirmed true dominant inheritance in some families, linked to specific MEFV gene variants affecting pyrin protein function.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) is typically an autosomal recessive autoinflammatory disease.
  • It is caused by mutations in the MEFV gene, encoding pyrin.
  • Autosomal dominant inheritance patterns have been questioned due to pseudo-dominance from carriers.

Purpose of the Study:

  • To investigate the inheritance patterns of FMF in families with apparent dominant transmission.
  • To identify specific MEFV gene mutations associated with dominant FMF.
  • To understand the role of pyrin variants in FMF pathogenesis.

Main Methods:

  • Comprehensive MEFV genotyping in five families with suspected dominant FMF.
  • Complete MEFV sequencing in affected individuals.
  • Analysis of silent single nucleotide polymorphisms to confirm transmission patterns.
  • Clinical evaluation of patients with dominantly inherited FMF.

Main Results:

  • True autosomal dominant FMF inheritance was confirmed in three of five families.
  • Dominant inheritance was associated with heterozygosity for pyrin DeltaM694 or E148Q/M694I variants.
  • No coding abnormalities were found in the other allele, indicating single-allele disease.
  • Clinical features, including AA amyloidosis, were typical for FMF.

Conclusions:

  • FMF can exhibit autosomal dominant inheritance with variable penetrance.
  • Specific pyrin variants, particularly at methionine residue 694, are crucial for FMF susceptibility.
  • Reduced pyrin activity (50% of normal) does not prevent FMF development in dominant cases.

Related Concept Videos